• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.25%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqGM
    0.63 Down 0.04(5.96%) Aug 3, 3:57PM EDT
    Add to Portfolio
    Prev Close:0.67
    Open:0.67
    Bid:0.01 x 100
    Ask:0.67 x 1000
    1y Target Est:9.00
    Beta:4.88
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:0.61 - 0.67
    52wk Range:0.51 - 3.72
    Volume:105,025
    Avg Vol (3m):218,812
    Market Cap:21.87M
    P/E (ttm):N/A
    EPS (ttm):-0.83
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYCC

    Comparison

    Symbol% ChgMkt Cap
    CYCCDown 5.96%21.87M
    AZNUp 0.44%42.90B
    JNJDown 0.19%277.36B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (Jun-15) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing small molecule drugs for the treatment of cancer and other serious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback